Digest Network Come funziona
Network
/
Società
As
Non verificato

Ascentage Pharma

Di cosa scriviamo

BancaBiologiaEconomiaFarmaceuticaSanità

4 comunicati stampa

Guarda tutti i comunicati
Press Release cover image
24/06/2024
Farmaceutica
Banca
Sanità
Economia
Titoli e azioni
Mercato azionario
Biologia
Ascentage Pharma Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering of American Depositary Shares
Fonte
Ascentage Pharma
Emittente
PR News Wire
1.00
0
Press Release cover image
21/06/2024
Farmaceutica
Banca
Sanità
Biologia
Ascentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda
Fonte
Ascentage Pharma
Emittente
PR News Wire
1.00
0
Press Release cover image
14/06/2024
Farmaceutica
Information Technology
Telecomunicazioni
Banca
Sanità
Economia
Brevetti, marchi e copyright
Biologia
Ascentage Pharma Signs Option Agreement with Takeda to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)
Fonte
Ascentage Pharma
Emittente
PR News Wire
1.00
0
Press Release cover image
11/06/2024
Farmaceutica
Information Technology
Telecomunicazioni
Banca
Sanità
Biologia
Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE
Fonte
Ascentage Pharma
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0